The FDA has approved Juxtapid (lomitapide), from Aegerion Pharma, as an adjunct to diet and other lipid-lowering treatments to reduce...
Aegerion Pharmaceuticals has announced that patient enrollment has been initiated in Japan in a clinical trial of Juxtapid / Lojuxta...
Amryt announces the signing of a distribution agreement with Medison Pharma Canada (“Medison”) to distribute Myalept (metreleptin) in Canada.
The European Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Lojuxta (lomitapide), from Aegerion Pharmaceuticals,...
The FDA 0n 29 January 2013 approved Kynamro (mipomersen sodium) injection, from Genzyme/Sanofi, as an addition to lipid-lowering medications and...
Aegerion Pharmaceuticals, Inc.and QLT Inc. have announced that they have entered into a definitive merger agreement under which Aegerion will...